Assessing molecular gene by treatment interactions using a population of neural progenitors exposed to valproic acid and lithium
Preprint
Abstract
Gene by treatment (GxT) interactions likely contribute to variability in clinical response, but are difficult to identify in population studies. Here, we applied psychiatric and neurological disorder treatments to a genotyped population of human neural progenitors (n=83 donors) and measured molecular responses on chromatin accessibility and gene expression. Gene regulatory responses to valproic acid (VPA), which is also a prenatal risk factor for autism, and lithium were highly enriched in genetic risk for psychiatric disorders, demonstrating the convergence of environmental and genetic factors. Genetic variation impacted molecular response to these drugs at over 1,000 loci, a subset of which modulated the impacts of psychiatric disorder risk variants. Finally, transcriptome-wide association revealed enzymes involved with folate metabolism during VPA exposure impact cognitive ability, a pathway previously shown to alleviate the negative impacts of this exposure. The “GxT in a dish” approach identified a validated treatment pathway, supporting its broad utility.Keywords
This publication has 123 references indexed in Scilit:
- Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In UteroJAMA Neurology, 2018
- Brief report novel mechanism for valproate‐induced teratogenicityBirth Defects Research Part A: Clinical and Molecular Teratology, 2014
- Detecting and Estimating Contamination of Human DNA Samples in Sequencing and Array-Based Genotype DataThe American Journal of Human Genetics, 2012
- Rare Deletions at the Neurexin 3 Locus in Autism Spectrum DisorderThe American Journal of Human Genetics, 2012
- Endogenous Wnt Signaling Maintains Neural Progenitor Cell PotencyStem Cells, 2009
- Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardationHuman Mutation, 2007
- Expression of Cux‐1 and Cux‐2 in the subventricular zone and upper layers II–IV of the cerebral cortexJournal of Comparative Neurology, 2004
- DLX-1, DLX-2, and DLX-5 expression define distinct stages of basal forebrain differentiationJournal of Comparative Neurology, 1999
- Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in miceFundamental and Applied Toxicology, 1992
- Distribution of valproate across the interface between blood and cerebrospinal fluidNeuropharmacology, 1978